Back
Vertex Pharmaceuticals Vs. Keros Therapeutics Industry Stock Comparison
Buy
63
VRTX
Vertex Pharmaceuticals
Last Price:
404.22
Seasonality Move:
10.13%
Sell
43
KROS
Keros Therapeutics
Last Price:
61.26
Seasonality Move:
-20.18%
Buy
63
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $401.08. The Score for VRTX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $60.57. The Score for KROS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $401.08
The current trend is relatively stagnant and VRTX is experiencing slight selling pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $60.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.73 | Sell |
| Relative Strength Index (14 RSI): | 48.64 | Sell |
| Chaikin Money Flow: | -144131 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (394.53 - 406.89) | Buy |
| Bollinger Bands (100): | (398.87 - 428.89) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.33 | Sell |
| Relative Strength Index (14 RSI): | 52.59 | Buy |
| Chaikin Money Flow: | 191481 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.41 - 62.79) | Buy |
| Bollinger Bands (100): | (45.59 - 66.39) | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 398.54 | Buy |
| 20-day SMA: | 398.43 | Buy |
| 50-day SMA: | 409.28 | Sell |
| 200-day SMA: | 384.62 | Buy |
| 8-day EMA: | 399.12 | Buy |
| 20-day EMA: | 400.55 | Buy |
| 50-day EMA: | 405.68 | Sell |
| 200-day EMA: | 386.45 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.32 | Buy |
| 20-day SMA: | 58.53 | Buy |
| 50-day SMA: | 63.26 | Sell |
| 200-day SMA: | 44.75 | Buy |
| 8-day EMA: | 57.98 | Buy |
| 20-day EMA: | 58.88 | Buy |
| 50-day EMA: | 59.57 | Buy |
| 200-day EMA: | 50.24 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.30 per share, an increase this year of $1.62 per share, and an increase next year of $1.37 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Vertex Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||